azatoxin has been researched along with somatostatin in 1 studies
| Studies (azatoxin) | Trials (azatoxin) | Recent Studies (post-2010) (azatoxin) | Studies (somatostatin) | Trials (somatostatin) | Recent Studies (post-2010) (somatostatin) |
|---|---|---|---|---|---|
| 11 | 0 | 2 | 29 | 0 | 11 |
| Protein | Taxonomy | azatoxin (IC50) | somatostatin (IC50) |
|---|---|---|---|
| Somatostatin receptor type 5 | Mus musculus (house mouse) | 0.0001 | |
| Protein-lysine 6-oxidase | Homo sapiens (human) | 0.01 | |
| Somatostatin receptor type 1 | Homo sapiens (human) | 0.0012 | |
| Somatostatin receptor type 1 | Mus musculus (house mouse) | 0.0001 | |
| Somatostatin receptor type 2 | Homo sapiens (human) | 0.0007 | |
| Somatostatin receptor type 2 | Mus musculus (house mouse) | 0.0002 | |
| Somatostatin receptor type 3 | Mus musculus (house mouse) | 0.0001 | |
| Somatostatin receptor type 5 | Rattus norvegicus (Norway rat) | 0.0009 | |
| Somatostatin receptor type 4 | Homo sapiens (human) | 0.0012 | |
| Somatostatin receptor type 3 | Homo sapiens (human) | 0.002 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 2 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.006 | |
| Somatostatin receptor type 5 | Homo sapiens (human) | 0.003 | |
| Somatostatin receptor type 4 | Mus musculus (house mouse) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazylevich, A; Bovina, A; Firer, MA; Gellerman, G; Hesin, A; Kostenich, G; Luboshits, G; Oron-Herman, M; Ragozin, E; Rubinek, T; Shekhter Zahavi, T; Sherman, MY; Tuchinsky, H; Wolf, I | 1 |
1 other study(ies) available for azatoxin and somatostatin
| Article | Year |
|---|---|
New somatostatin-drug conjugates for effective targeting pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Humans; Indoles; Kidney; Pancreatic Neoplasms; Peptides, Cyclic; Receptors, Somatostatin; Somatostatin; Stilbenes; Tissue Distribution; Xenograft Model Antitumor Assays | 2018 |